Two recent Stanford-led studies show the value of tweaking vaccines to enlist the entire immune system — not just part of it — in preventing HIV infection.
A Stanford microbiologist describes the invigorating, yet sobering race to develop an effective vaccine against COVID-19.
Mammalian cells use a label to distinguish self from non-self circular RNA molecules. Foreign molecules can trigger anti-cancer immune responses.
The best time to get a flu shot is when you haven't had antibiotics recently, a new study has found, because healthy gut bacteria protect immunity.
In this In the Spotlight, Rebecca Saenz, a recent allergy and immunology fellow, describes her evolution as a physician/scientist and entrepreneur.
Osteoarthritis has traditionally been thought to be an inevitable result of wear and tear. But it's now clear the immune system is playing a leading role.
Stanford scientists and collaborators have harnessed CRISPR to replace the mutated gene underpinning the devastating immune disease, SCID-X1.
P. aeruginosa, a type of bacteria, is increasingly drug-resistant, and there's no vaccine against it. But it has a recently discovered Achilles heel.
Scientists have modified immune cells, imbuing them with the ability to not only detect, but reveal, the presence of a tumor.
Cracking the crystal structure of a protein complex centered around a major immune signaling protein, interferon-gamma, may speed its medical use.
A team of researchers have found a new way to remove blood-producing stem cells, introducing the possibility of safer, and non-matched, transplants.
Sharon Chinthrajah weighs in on a new peanut allergy immunotherapy, speaking to its potential and its role in the future of food allergies therapy.
With age comes wisdom: mostly true. But a new study helps explain why one part of us - our immune system - gets decidedly dumber with age.
Geneticist Michael Snyder has tracked the expression of his genes for three years, focusing on changes in response to chronic or acute disease.
Much of what we know about the immune system comes from experiments conducted on mice. But lab mice are not little human beings. The two species are separated by both physiology and lifestyles. Stanford immunologist Mark Davis is calling on his colleagues to shift their research focus to people.
Hiding mRNA messages in CARTs — positively charged degradable vehicles —smuggles them across the cell membrane and can 'vaccinate' against cancer in mice.